Role of non-homologous end joining in V(D)J recombination

Immunologic Research

Volumn 54, Issue 1-3, 2012, Pages 233-246

  Malu, Shruti ^a,b   Malshetty, Vidyasagar ^a   Francis, Dailia ^a   Cortes, Patricia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Genomic stability; Immunodeficiencies; Non homologous end joining (NHEJ); V(D)J recombination

Indexed keywords

DNA; T LYMPHOCYTE RECEPTOR;

DNA END JOINING REPAIR; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN VARIABLE REGION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY;

ANIMALS; DNA END-JOINING REPAIR; HUMANS; MODELS, MOLECULAR; SEVERE COMBINED IMMUNODEFICIENCY; V(D)J RECOMBINATION;

EID: 84867847788     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-012-8329-z     Document Type: Review

References (185)

1. Tonegawa S. Somatic generation of antibody diversity. Nature. 1983;302(5909):575-81.
2. Jung D, Alt FW. Unraveling V(D)J recombination; insights into gene regulation. Cell. 2004;116(2):299-311.
3. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell. 2002;109(Suppl):S45-55.
4. West KL, Singha NC, De Ioannes P, Lacomis L, Erdjument-Bromage H, Tempst P, et al. A direct interaction between the RAG2 C terminus and the core histones is required for efficient V(D)J recombination. Immunity. 2005;23(2):203-12. doi: 10.1016/j.immuni.2005.07.004.
5. Liu Y, Subrahmanyam R, Chakraborty T, Sen R, Desiderio S. A plant homeodomain in RAG-2 that binds hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. Immunity. 2007;27(4):561-71. doi: 10.1016/j.immuni.2007.09.005.
6. Matthews AG, Kuo AJ, Ramon-Maiques S, Han S, Champagne KS, Ivanov D, et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature. 2007;450(7172):1106-10. doi: 10.1038/nature06431.
7. Ramon-Maiques S, Kuo AJ, Carney D, Matthews AG, Oettinger MA, Gozani O, et al. The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc Natl Acad Sci USA. 2007;104(48):18993-8. doi: 10.1073/pnas.0709170104.
8. Agrawal A, Schatz DG. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell. 1997;89(1):43-53.
9. Gu Y, Seidl KJ, Rathbun GA, Zhu C, Manis JP, van der Stoep N, et al. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity. 1997;7(5):653-65.
10. Zhu C, Bogue MA, Lim DS, Hasty P, Roth DB. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell. 1996;86(3):379-89.
11. Nussenzweig A, Chen C, da Costa Soares V, Sanchez M, Sokol K, Nussenzweig MC, et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 1996;382(6591):551-5.
12. Roth DB, Menetski JP, Nakajima PB, Bosma MJ, Gellert M. V(D)J recombination: broken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes. Cell. 1992;70(6):983-91.
13. Besmer E, Mansilla-Soto J, Cassard S, Sawchuk DJ, Brown G, Sadofsky M, et al. Hairpin coding end opening is mediated by RAG1 and RAG2 proteins. Mol Cell. 1998;2(6):817-28.
14. Shockett PE, Schatz DG. DNA hairpin opening mediated by the RAG1 and RAG2 proteins. Mol Cell Biol. 1999;19(6):4159-66.
15. Paull TT, Gellert M. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev. 1999;13(10):1276-88.
16. Ma Y, Pannicke U, Schwarz K, Lieber MR. Hairpin opening and overhang procesing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell. 2002;108:781-94.
17. Santagata S, Besmer E, Villa A, Bozzi F, Allingham JS, Sobacchi C, et al. The RAG1/RAG2 complex constitutes a 3′ flap endonuclease: implications for junctional diversity in V(D)J and transpositional recombination. Mol Cell. 1999;4(6):935-47.
18. Gu J, Li S, Zhang X, Wang LC, Niewolik D, Schwarz K, et al. DNA-PKcs regulates a single-stranded DNA endonuclease activity of Artemis. DNA Repair. 2010;9(4):429-37. doi: 10.1016/j.dnarep.2010.01.001.
19. Paull TT, Gellert M. The 3′ to 5′ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. Mol Cell. 1998;1(7):969-79.
20. Rooney S, Sekiguchi J, Zhu C, Cheng HL, Manis J, Whitlow S, et al. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell. 2002;10(6):1379-90.
21. Grawunder U, Zimmer D, Fugmann S, Schwarz K, Lieber MR. DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol Cell. 1998;2(4):477-84.
22. Dahm K. Role and regulation of human XRCC4-like factor/cernunnos. J Cell Biochem. 2008;104(5):1534-40. doi: 10.1002/jcb.21726.
23. Bertocci B, De Smet A, Berek C, Weill JC, Reynaud CA. Immunoglobulin kappa light chain gene rearrangement is impaired in mice deficient for DNA polymerase mu. Immunity. 2003;19(2):203-11.
24. Bertocci B, De Smet A, Weill JC, Reynaud CA. Nonoverlapping functions of DNA polymerases mu, lambda, and terminal deoxynucleotidyltransferase during immunoglobulin V(D)J recombination in vivo. Immunity. 2006;25(1):31-41. doi: 10.1016/j.immuni.2006.04.013.
25. Desiderio SV, Yancopoulos GD, Paskind M, Thomas E, Boss MA, Landau N, et al. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature. 1984;311(5988):752-5.
26. Mansilla-Soto J, Cortes P. VDJ recombination: Artemis and its in vivo role in hairpin opening. J Exp Med. 2003;197(5):543-7.
27. Ramsden DA. Polymerases in nonhomologous end joining: building a bridge over broken chromosomes. Antioxid Redox Signal. 2011;14(12):2509-19. doi: 10.1089/ars.2010.3429.
28. Lewis SM. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses. Adv Immunol. 1994;56:27-150.
29. Fischer A, Cavazzana-Calvo M, De Saint Basile G, Cavazzana-Calvo M, De Villartay JP, Di Santo JP, Hivroz C, et al. Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol. 1997;15:93-124. doi: 10.1146/annurev.immunol.15.1.93.
30. Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 1997;130(3):378-87.
31. Fischer A, LeDeist F, Hacein-Bey-Abina S, Andre-Schmutz I, Basile Gde S, de Villartay JP, et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol Rev. 2005;203:98-109. doi: 10.1111/j.0105-2896.2005.00223.x.
32. Fischer A. Primary immunodeficiency diseases: an experimental model for molecular medicine. Lancet. 2001;357(9271):1863-9. doi: 10.1016/S0140-6736(00) 04959-X.
33. Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97(1):81-8.
34. Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F, et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 2001;105(2):177-86.
35. Enders A, Fisch P, Schwarz K, Duffner U, Pannicke U, Nikolopoulos E, et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol. 2006;176(8):5060-8.
36. Buck D, Malivert L, de Chasseval R, Barraud A, Fondaneche MC, Sanal O, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell. 2006;124(2):287-99. doi: 10.1016/j.cell.2005.12.030.
37. Cagdas D, Ozgur TT, Asal GT, Revy P, De Villartay JP, van der Burg M, et al. Two SCID cases with Cernunnos-XLF deficiency successfully treated by hematopoietic stem cell transplantation. Pediatr Transplant. 2011;. doi: 10.1111/j.1399-3046.2011.01491.x.
38. van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, Morotomi-Yano K, et al. A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining. J Clin Invest. 2009;119(1):91-8. doi: 10.1172/JCI37141.
39. Moshous D, Pannetier C, Chasseval Rd R, Deist Fl F, Cavazzana-Calvo M, Romana S, et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest. 2003;111(3):381-7.
40. Nijnik A, Dawson S, Crockford TL, Woodbine L, Visetnoi S, Bennett S, et al. Impaired lymphocyte development and antibody class switching and increased malignancy in a murine model of DNA ligase IV syndrome. J Clin Invest. 2009;119(6):1696-705. doi: 10.1172/JCI32743.
41. Musio A, Marrella V, Sobacchi C, Rucci F, Fariselli L, Giliani S, et al. Damaging-agent sensitivity of Artemis-deficient cell lines. Eur J Immunol. 2005;35(4):1250-6.
42. van der Burg M, Verkaik NS, den Dekker AT, Barendregt BH, Pico-Knijnenburg I, Tezcan I, et al. Defective Artemis nuclease is characterized by coding joints with microhomology in long palindromic-nucleotide stretches. Eur J Immunol. 2007;37(12):3522-8. doi: 10.1002/eji.200737624.
43. O'Driscoll M, Gennery AR, Seidel J, Concannon P, Jeggo PA. An overview of three new disorders associated with genetic instability: LIG4 syndrome. RS-SCID and ATR-Seckel syndrome. DNA Repair (Amst). 2004;3(8-9):1227-35. doi: 10.1016/j.dnarep.2004.03.025.
44. Marrella V, Poliani PL, Sobacchi C, Grassi F, Villa A. Of Omenn and mice. Trends Immunol. 2008;29(3):133-40.
45. Omenn GS. Familial reticuloendotheliosis with eosinophilia. N Engl J Med. 1965;273:427-32. doi: 10.1056/NEJM196508192730806.
46. Aleman K, Noordzij JG, de Groot R, van Dongen JJ, Hartwig NG. Reviewing Omenn syndrome. Eur J Pediatr. 2001;160(12):718-25.
47. Mazzolari E, Moshous D, Forino C, De Martiis D, Offer C, Lanfranchi A, et al. Hematopoietic stem cell transplantation in Omenn syndrome: a single-center experience. Bone Marrow Transplant. 2005;36(2):107-14. doi: 10.1038/sj.bmt. 1705017.
48. Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 1998;93(5):885-96.
49. Corneo B, Moshous D, Gungor T, Wulffraat N, Philippet P, Le Deist FL, et al. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood. 2001;97(9):2772-6.
50. Ege M, Ma Y, Manfras B, Kalwak K, Lu H, Lieber MR et al. Omenn syndrome due to ARTEMIS mutations. Blood. 2005;105(11):4179-86.
51. Marrella V, Maina V, Villa A. Omenn syndrome does not live by V(D)J recombination alone. Curr Opin Allergy Clin Immunol. 2011;11(6):525-31. doi: 10.1097/ACI.0b013e32834c311a.
52. Couedel C, Roman C, Jones A, Vezzoni P, Villa A, Cortes P. Analysis of mutations from SCID and Omenn syndrome patients reveals the central role of the Rag2 PHD domain in regulating V(D)J recombination. J Clin Investig. 2010;120(4):1337-44. doi: 10.1172/JCI41305.
53. Shrivastav M, De Haro LP, Nickoloff JA. Regulation of DNA double-strand break repair pathway choice. Cell Res. 2008;18(1):134-47. doi: 10.1038/cr.2007.111.
54. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature. 2001;411(6835):366-74. doi: 10.1038/35077232.
55. Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell. 2007;28(5):739-45. doi: 10.1016/j.molcel.2007.11.015.
56. Allen C, Halbrook J, Nickoloff JA. Interactive competition between homologous recombination and non-homologous end joining. Mol Cancer Res. 2003;1(12):913-20.
57. Richardson C, Jasin M. Coupled homologous and nonhomologous repair of a double-strand break preserves genomic integrity in mammalian cells. Mol Cell Biol. 2000;20(23):9068-75.
58. Johnson RD, Jasin M. Double-strand-break-induced homologous recombination in mammalian cells. Biochem Soc Trans. 2001;29(Pt 2):196-201.
59. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 2002;23(5):687-96.
60. Lees-Miller SP, Meek K. Repair of DNA double strand breaks by non-homologous end joining. Biochimie. 2003;85(11):1161-73.
61. Weterings E, van Gent DC. The mechanism of non-homologous end-joining: a synopsis of synapsis. DNA Repair (Amst). 2004;3(11):1425-35. doi: 10.1016/j.dnarep.2004.06.003.
62. Smith GC, Jackson SP. The DNA-dependent protein kinase. Genes Dev. 1999;13(8):916-34.
63. DeFazio LG, Stansel RM, Griffith JD, Chu G. Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J. 2002;21(12):3192-200. doi: 10.1093/emboj/cdf299.
64. Dobbs TA, Tainer JA, Lees-Miller SP. A structural model for regulation of NHEJ by DNA-PKcs autophosphorylation. DNA Repair. 2010;9(12):1307-14. doi: 10.1016/j.dnarep.2010.09.019.
65. Riballo E, Kuhne M, Rief N, Doherty A, Smith GC, Recio MJ, et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol Cell. 2004;16(5):715-24. doi: 10.1016/j.molcel.2004.10.029.
66. Nick McElhinny SA, Havener JM, Garcia-Diaz M, Juarez R, Bebenek K, Kee BL et al. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining. Mol Cell. 2005;19(3):357-66.doi: 10.1016/j.molcel.2005.06.012.
67. Weill JC, Reynaud CA. DNA polymerases in adaptive immunity. Nat Rev Immunol. 2008;8(4):302-12. doi: 10.1038/nri2281.
68. Roberts SA, Strande N, Burkhalter MD, Strom C, Havener JM, Hasty P, et al. Ku is a 5′-dRP/AP lyase that excises nucleotide damage near broken ends. Nature. 2010;464(7292):1214-7. doi: 10.1038/nature08926.
69. Li S, Kanno S, Watanabe R, Ogiwara H, Kohno T, Watanabe G, et al. Polynucleotide kinase and aprataxin-like forkhead-associated protein (PALF) acts as both a single-stranded DNA endonuclease and a single-stranded DNA 3′ exonuclease and can participate in DNA end joining in a biochemical system. J Biol Chem. 2011;286(42):36368-77. doi: 10.1074/jbc.M111.287797.
70. Mahaney BL, Meek K, Lees-Miller SP. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J. 2009;417(3):639-50. doi: 10.1042/BJ20080413.
71. Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181-211. doi: 10.1146/annurev.biochem.052308.093131.
72. Helmink BA, Bredemeyer AL, Lee BS, Huang CY, Sharma GG, Walker LM, et al. MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks. J Exp Med. 2009;206(3):669-79. doi: 10.1084/jem.20081326.
73. Bothmer A, Robbiani DF, Feldhahn N, Gazumyan A, Nussenzweig A, Nussenzweig MC. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J Exp Med. 2010;207(4):855-65. doi: 10.1084/jem.20100244.
74. Ma Y, Lu H, Schwarz K, Lieber MR. Repair of Double-Strand DNA Breaks by the Human Nonhomologous DNA End Joining Pathway: The Iterative Processing Model. Cell Cycle. 2005;4(9):1193-200.
75. Lieber MR. The mechanism of human nonhomologous DNA end joining. J Biol Chem. 2008;283(1):1-5.
76. Ma Y, Schwarz K, Lieber MR. The Artemis: DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps. DNA Repair. 2005;4:845-51.
77. Ma Y, Lu H, Tippin B, Goodman MF, Shimazaki N, Koiwai O, et al. A biochemically defined system for mammalian nonhomologous DNA end joining. Mol Cell. 2004;16(5):701-13.
78. Yano K, Morotomi-Yano K, Wang SY, Uematsu N, Lee KJ, Asaithamby A, et al. Ku recruits XLF to DNA double-strand breaks. EMBO Rep. 2008;9(1):91-6. doi: 10.1038/sj.embor.7401137.
79. Mari PO, Florea BI, Persengiev SP, Verkaik NS, Bruggenwirth HT, Modesti M, et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc Natl Acad Sci USA. 2006;103(49):18597-602. doi: 10.1073/pnas.0609061103.
80. Uematsu N, Weterings E, Yano K, Morotomi-Yano K, Jakob B, Taucher-Scholz G, et al. Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks. J Cell Biol. 2007;177(2):219-29. doi: 10.1083/jcb. 200608077.
81. Yano K, Chen DJ. Live cell imaging of XLF and XRCC4 reveals a novel view of protein assembly in the non-homologous end-joining pathway. Cell Cycle. 2008;7(10):1321-5.
82. Yano K, Morotomi-Yano K, Adachi N, Akiyama H. Molecular mechanism of protein assembly on DNA double-strand breaks in the non-homologous end-joining pathway. J Radiat Res (Tokyo). 2009;50(2):97-108.
83. Costantini S, Woodbine L, Andreoli L, Jeggo PA, Vindigni A. Interaction of the Ku heterodimer with the DNA ligase IV/Xrcc4 complex and its regulation by DNA-PK. DNA Repair (Amst). 2007.
84. Revy P, Buck D, le Deist F, de Villartay JP. The repair of DNA damages/modifications during the maturation of the immune system: lessons from human primary immunodeficiency disorders and animal models. Adv Immunol. 2005;87:237-95. doi: 10.1016/S0065-2776(05)87007-5.
85. Gostissa M, Alt FW, Chiarle R. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu Rev Immunol. 2011;29:319-50. doi: 10.1146/annurev-immunol-031210-101329.
86. Nussenzweig A, Nussenzweig MC. Origin of chromosomal translocations in lymphoid cancer. Cell. 2010;141(1):27-38. doi: 10.1016/j.cell.2010.03.016.
87. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature. 1983;301(5900):527-30.
88. Lieber MR, Hesse JE, Lewis S, Bosma GC, Rosenberg N, Mizuuchi K, et al. The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell. 1988;55(1):7-16.
89. Taccioli GE, Rathbun G, Oltz E, Stamato T, Jeggo PA, Alt FW. Impairment of V(D)J recombination in double-strand break repair mutants. Science. 1993;260(5105):207-10.
90. Dudley DD, Chaudhuri J, Bassing CH, Alt FW. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. Adv Immunol. 2005;86:43-112. doi: 10.1016/S0065-2776(04)86002-4.
91. Dai Y, Kysela B, Hanakahi LA, Manolis K, Riballo E, Stumm M, et al. Nonhomologous end joining and V(D)J recombination require an additional factor. Proc Natl Acad Sci U S A. 2003;100(5):2462-7. doi: 10.1073/pnas.0437964100.
92. Ahnesorg P, Smith P, Jackson SP. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell. 2006;124(2):301-13. doi: 10.1016/j.cell.2005.12.031.
93. Sawchuk DJ, Mansilla-Soto J, Alarcon C, Singha NC, Langen H, Bianchi ME, et al. Ku70/Ku80 and DNA-dependent protein kinase catalytic subunit modulate RAG-mediated cleavage: implications for the enforcement of the 12/23 rule. J Biol Chem. 2004;279(28):29821-31. doi: 10.1074/jbc.M403706200.
94. Raval P, Kriatchko AN, Kumar S, Swanson PC. Evidence for Ku70/Ku80 association with full-length RAG1. Nucleic Acids Res. 2008;36(6):2060-72. doi: 10.1093/nar/gkn049.
95. Brandt VL, Roth DB. A recombinase diversified: new functions of the RAG proteins. Curr Opin Immunol. 2002;14(2):224-9.
96. Tsai CL, Drejer AH, Schatz DG. Evidence of a critical architectural function for the RAG proteins in end processing, protection, and joining in V(D)J recombination. Genes Dev. 2002;16(15):1934-49. doi: 10.1101/gad.984502.
97. Jones JM, Simkus C. The roles of the RAG1 and RAG2 non-core regions in V(D)J recombination and lymphocyte development. Arch Immunol Ther Exp (Warsz). 2009;57(2):105-16. doi: 10.1007/s00005-009-0011-3.
98. Jones JM, Bhattacharyya A, Simkus C, Vallieres B, Veenstra TD, Zhou M. The RAG1 V(D)J recombinase/ubiquitin ligase promotes ubiquitylation of acetylated, phosphorylated histone 3.3. Immunol Lett. 2011;136(2):156-62. doi: 10.1016/j.imlet.2011.01.005.
99. Corneo B, Wendland RL, Deriano L, Cui X, Klein IA, Wong SY, et al. Rag mutations reveal robust alternative end joining. Nature. 2007;449(7161):483-6. doi: 10.1038/nature06168.
100. Cui X, Meek K. Linking double-stranded DNA breaks to the recombination activating gene complex directs repair to the nonhomologous end-joining pathway. Proc Natl Acad Sci USA. 2007;104(43):17046-51. doi: 10.1073/pnas.0610928104.
101. Deriano L, Chaumeil J, Coussens M, Multani A, Chou Y, Alekseyenko AV, et al. The RAG2 C terminus suppresses genomic instability and lymphomagenesis. Nature. 2011;471(7336):119-23. doi: 10.1038/nature09755.
102. Puebla-Osorio N, Zhu C. DNA damage and repair during lymphoid development: antigen receptor diversity, genomic integrity and lymphomagenesis. Immunol Res. 2008;41(2):103-22.
103. Jones JM, Gellert M. Autoubiquitylation of the V(D)J recombinase protein RAG1. Proc Nat Acad Sci USA. 2003;100(26):15446-51. doi: 10.1073/pnas. 2637012100.
104. Grazini U, Zanardi F, Citterio E, Casola S, Goding CR, McBlane F. The RING domain of RAG1 ubiquitylates histone H3: a novel activity in chromatin-mediated regulation of V(D)J joining. Mol Cell. 2010;37(2):282-93. doi: 10.1016/j.molcel.2009.12.035.
105. Kassmeier MD, Mondal K, Palmer VL, Raval P, Kumar S, Perry GA, et al. VprBP binds full-length RAG1 and is required for B-cell development and V(D)J recombination fidelity. EMBO J. 2011;. doi: 10.1038/emboj.2011.455.
106. Downs JA, Jackson SP. A means to a DNA end: the many roles of Ku. Nat Rev Mol Cell Biol. 2004;5(5):367-78.
107. Lan L, Ui A, Nakajima S, Hatakeyama K, Hoshi M, Watanabe R, et al. The ACF1 complex is required for DNA double-strand break repair in human cells. Mol Cell. 2010;40(6):976-87. doi: 10.1016/j.molcel.2010.12.003.
108. Yoo S, Dynan WS. Geometry of a complex formed by double strand break repair proteins at a single DNA end: recruitment of DNA-PKcs induces inward translocation of Ku protein. Nucleic Acids Res. 1999;27(24):4679-86.
109. Drouet J, Delteil C, Lefrancois J, Concannon P, Salles B, Calsou P. DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks. J Biol Chem. 2005;280(8):7060-9.
110. Bogue MA, Wang C, Zhu C, Roth DB. V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation. Immunity. 1997;7(1):37-47.
111. Mahajan KN, Gangi-Peterson L, Sorscher DH, Wang J, Gathy KN, Mahajan NP, et al. Association of terminal deoxynucleotidyl transferase with Ku. Proc Natl Acad Sci USA. 1999;96(24):13926-31.
112. Nick McElhinny SA, Snowden CM, McCarville J, Ramsden DA. Ku recruits the XRCC4-ligase IV complex to DNA ends. Mol Cell Biol. 2000;20(9):2996-3003.
113. Weterings E, Verkaik NS, Keijzers G, Florea BI, Wang SY, Ortega LG, et al. The Ku80 carboxy terminus stimulates joining and artemis-mediated processing of DNA ends. Mol Cell Biol. 2009;29(5):1134-42. doi: 10.1128/MCB.00971-08.
114. Mahajan KN, Nick McElhinny SA, Mitchell BS, Ramsden DA. Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for pol mu in end-joining double-strand break repair. Mol Cell Biol. 2002;22(14):5194-202.
115. Gottlieb TM, Jackson SP. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell. 1993;72(1):131-42.
116. Gao Y, Chaudhuri J, Zhu C, Davidson L, Weaver DT, Alt FW. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity. 1998;9(3):367-76.
117. Gell D, Jackson SP. Mapping of protein-protein interactions within the DNA-dependent protein kinase complex. Nucleic Acids Res. 1999;27(17):3494-502.
118. Calsou P, Delteil C, Frit P, Drouet J, Salles B. Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment. J Mol Biol. 2003;326(1):93-103.
119. Hsu HL, Yannone SM, Chen DJ. Defining interactions between DNA-PK and ligase IV/XRCC4. DNA Repair (Amst). 2002;1(3):225-35.
120. Leber R, Wise TW, Mizuta R, Meek K. The XRCC4 gene product is a target for and interacts with the DNA-dependent protein kinase. J Biol Chem. 1998;273(3):1794-801.
121. Kienker LJ, Shin EK, Meek K. Both V(D)J recombination and radioresistance require DNA-PK kinase activity, though minimal levels suffice for V(D)J recombination. Nucleic Acids Res. 2000;28(14):2752-61.
122. Kurimasa A, Kumano S, Boubnov NV, Story MD, Tung CS, Peterson SR, et al. Requirement for the kinase activity of human DNA-dependent protein kinase catalytic subunit in DNA strand break rejoining. Mol Cell Biol. 1999;19(5):3877-84.
123. Douglas P, Gupta S, Morrice N, Meek K, Lees-Miller SP. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining. DNA Repair (Amst). 2005;4(9):1006-18.
124. Ma Y, Pannicke U, Lu H, Niewolik D, Schwarz K, Lieber MR. The DNA-PKcs phosphorylation sites in human artemis. J Biol Chem. 2005;280(40):33839-46.
125. Yu Y, Wang W, Ding Q, Ye R, Chen D, Merkle D, et al. DNA-PK phosphorylation sites in XRCC4 are not required for survival after radiation or for V(D)J recombination. DNA Repair (Amst). 2003;2(11):1239-52.
126. Yu Y, Mahaney BL, Yano K, Ye R, Fang S, Douglas P, et al. DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks. DNA Repair (Amst). 2008;7(10):1680-92.
127. Geng L, Zhang X, Zheng S, Legerski RJ. Artemis Links ATM to G2/M Checkpoint Recovery Via Regulation of Cdk1-Cyclin B. Mol Cell Biol. 2007;27(7):2625-35.
128. Chan DW, Chen BP, Prithivirajsingh S, Kurimasa A, Story MD, Qin J, et al. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev. 2002;16(18):2333-8.
129. Ding Q, Reddy YV, Wang W, Woods T, Douglas P, Ramsden DA, et al. Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol Cell Biol. 2003;23(16):5836-48.
130. Meek K, Dang V, Lees-Miller SP. DNA-PK: the means to justify the ends? Adv Immunol. 2008;99:33-58.
131. Roy S, Andres SN, Vergnes A, Neal JA, Xu Y, Yu Y et al. XRCC4's interaction with XLF is required for coding (but not signal) end joining. Nucleic acids research. 2012. doi: 10.1093/nar/gkr1315.
132. Malewicz M, Kadkhodaei B, Kee N, Volakakis N, Hellman U, Viktorsson K, et al. Essential role for DNA-PK-mediated phosphorylation of NR4A nuclear orphan receptors in DNA double-strand break repair. Genes Dev. 2011;25(19):2031-40. doi: 10.1101/gad.16872411.
133. Poinsignon C, Moshous D, Callebaut I, de Chasseval R, Villey I, de Villartay JP. The metallo-beta-lactamase/beta-CASP domain of Artemis constitutes the catalytic core for V(D)J recombination. J Exp Med. 2004;199(3):315-21.
134. Soubeyrand S, Pope L, De Chasseval R, Gosselin D, Dong F, de Villartay JP, et al. Artemis phosphorylated by DNA-dependent protein kinase associates preferentially with discrete regions of chromatin. J Mol Biol. 2006;358(5):1200-11. doi: 10.1016/j.jmb.2006.02.061.
135. Niewolik D, Pannicke U, Lu H, Ma Y, Wang LC, Kulesza P, et al. DNA-PKcs dependence of Artemis endonucleolytic activity, differences between hairpins and 5' or 3' overhangs. J Biol Chem. 2006;281(45):33900-9. doi: 10.1074/jbc.M606023200.
136. Goodarzi AA, Yu Y, Riballo E, Douglas P, Walker SA, Ye R, et al. DNA-PK autophosphorylation facilitates Artemis endonuclease activity. EMBO J. 2006;25(16):3880-9.
137. Evans PM, Woodbine L, Riballo E, Gennery AR, Hubank M, Jeggo PA. Radiation-induced delayed cell death in a hypomorphic Artemis cell line. Hum Mol Genet. 2006;15(8):1303-11.
138. Dudasova Z, Chovanec M. Artemis, a novel guardian of the genome. Neoplasma. 2003;50(5):311-8.
139. Pannicke U, Honig M, Schulze I, Rohr J, Heinz GA, Braun S, et al. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events. Hum Mutat. 2010;31(2):197-207. doi: 10.1002/humu.21168.
140. Poinsignon C, de Chasseval R, Soubeyrand S, Moshous D, Fischer A, Hache RJ, et al. Phosphorylation of Artemis following irradiation-induced DNA damage. Eur J Immunol. 2004;34(11):3146-55.
141. Huang Y, Giblin W, Kubec M, Westfield G, St Charles J, Chadde L et al. Impact of a hypomorphic Artemis disease allele on lymphocyte development, DNA end processing, and genome stability. J Exp Med. 2009;206(4):893-908.
142. Jacobs C, Huang Y, Masud T, Lu W, Westfield G, Giblin W et al. A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis. Hum Mol Genet.20(4):806-19. doi: 10.1093/hmg/ddq524.
143. Grawunder U, Zimmer D, Fugmann S, Schwarz K, Lieber MR. DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol Cell. 1998;2(4):477-84.
144. Wei YF, Robins P, Carter K, Caldecott K, Pappin DJ, Yu GL, et al. Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination. Mol Cell Biol. 1995;15(6):3206-16.
145. Li Z, Otevrel T, Gao Y, Cheng HL, Seed B, Stamato TD, et al. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell. 1995;83(7):1079-89.
146. Grawunder U, Wilm M, Wu X, Kulesza P, Wilson TE, Mann M, et al. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature. 1997;388(6641):492-5. doi: 10.1038/41358.
147. Ellenberger T, Tomkinson AE. Eukaryotic DNA ligases: structural and functional insights. Annu Rev Biochem. 2008;77:313-38. doi: 10.1146/annurev. biochem.77.061306.123941.
148. Grawunder U, Zimmer D, Leiber MR. DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains. Curr Biol. 1998;8(15):873-6.
149. Wu PY, Frit P, Meesala S, Dauvillier S, Modesti M, Andres SN, et al. Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4. Mol Cell Biol. 2009;29(11):3163-72. doi: 10.1128/MCB.01895-08.
150. Leung CC, Glover JN. BRCT domains: easy as one, two, three. Cell Cycle. 2011;10(15):2461-70.
151. Yu X, Chini CC, He M, Mer G, Chen J. The BRCT domain is a phospho-protein binding domain. Science. 2003;302(5645):639-42. doi: 10.1126/science.1088753.
152. Manke IA, Lowery DM, Nguyen A, Yaffe MB. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science. 2003;302(5645):636-9. doi: 10.1126/science.1088877.
153. Lee KJ, Jovanovic M, Udayakumar D, Bladen CL, Dynan WS. Identification of DNA-PKcs phosphorylation sites in XRCC4 and effects of mutations at these sites on DNA end joining in a cell-free system. DNA Repair (Amst). 2004;3(3):267-76. doi: 10.1016/j.dnarep.2003.11.005.
154. Modesti M, Hesse JE, Gellert M. DNA binding of Xrcc4 protein is associated with V(D)J recombination but not with stimulation of DNA ligase IV activity. EMBO J. 1999;18(7):2008-18. doi: 10.1093/emboj/18.7.2008.
155. Grawunder U, Zimmer D, Kulesza P, Lieber MR. Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo. J Biol Chem. 1998;273(38):24708-14.
156. Bryans M, Valenzano MC, Stamato TD. Absence of DNA ligase IV protein in XR-1 cells: evidence for stabilization by XRCC4. Mutat Res. 1999;433(1):53-8.
157. Mani RS, Yu Y, Fang S, Lu M, Fanta M, Zolner AE, et al. Dual modes of interaction between XRCC4 and polynucleotide kinase/phosphatase: implications for nonhomologous end joining. J Biol Chem. 2010;285(48):37619-29. doi: 10.1074/jbc.M109.058719.
158. Koch CA, Agyei R, Galicia S, Metalnikov P, O'Donnell P, Starostine A, et al. Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. EMBO J. 2004;23(19):3874-85. doi: 10.1038/sj.emboj.7600375.
159. Chappell C, Hanakahi LA, Karimi-Busheri F, Weinfeld M, West SC. Involvement of human polynucleotide kinase in double-strand break repair by non-homologous end joining. EMBO J. 2002;21(11):2827-32. doi: 10.1093/emboj/21.11.2827.
160. Barnes DE, Stamp G, Rosewell I, Denzel A, Lindahl T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr Biol. 1998;8(25):1395-8.
161. Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ, et al. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell. 1998;95(7):891-902.
162. Frank KM, Sekiguchi JM, Seidl KJ, Swat W, Rathbun GA, Cheng HL, et al. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature. 1998;396(6707):173-7. doi: 10.1038/24172.
163. Frank KM, Sharpless NE, Gao Y, Sekiguchi JM, Ferguson DO, Zhu C, et al. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell. 2000;5(6):993-1002. doi: S1097-2765(00)80264-6.
164. Gatz SA, Ju L, Gruber R, Hoffmann E, Carr AM, Wang ZQ et al. Requirement for DNA ligase IV during embryonic neuronal development. J Neurosci.31(27): 10088-100. doi: 10.1523/JNEUROSCI.1324-11.2011.
165. Badie C, Goodhardt M, Waugh A, Doyen N, Foray N, Calsou P, et al. A DNA double-strand break defective fibroblast cell line (180BR) derived from a radiosensitive patient represents a new mutant phenotype. Cancer Res. 1997;57(20):4600-7.
166. Chistiakov DA, Voronova NV, Chistiakov AP. Ligase IV syndrome. Eur J Med Genet. 2009;52(6):373-8. doi: 10.1016/j.ejmg.2009.05.009.
167. O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell. 2001;8(6):1175-85. doi: S1097-2765(01)00408-7.
168. Smith J, Riballo E, Kysela B, Baldeyron C, Manolis K, Masson C, et al. Impact of DNA ligase IV on the fidelity of end joining in human cells. Nucleic Acids Res. 2003;31(8):2157-67.
169. Li G, Alt FW, Cheng HL, Brush JW, Goff PH, Murphy MM, et al. Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination. Mol Cell. 2008;31(5):631-40.
170. Zha S, Guo C, Boboila C, Oksenych V, Cheng HL, Zhang Y, et al. ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks. Nature. 2011;469(7329):250-4. doi: 10.1038/nature09604.
171. Andres SN, Modesti M, Tsai CJ, Chu G, Junop MS. Crystal structure of human XLF: a twist in nonhomologous DNA end-joining. Mol Cell. 2007;28(6):1093-101.
172. Li Y, Chirgadze DY, Bolanos-Garcia VM, Sibanda BL, Davies OR, Ahnesorg P, et al. Crystal structure of human XLF/Cernunnos reveals unexpected differences from XRCC4 with implications for NHEJ. EMBO J. 2008;27(1):290-300.
173. Dahm K. Role and regulation of human XRCC4-like factor/cernunnos. J Cell Biochem. 2008;104(5):1534-40.
174. Callebaut I, Malivert L, Fischer A, Mornon JP, Revy P, de Villartay JP. Cernunnos interacts with the XRCC4 x DNA-ligase IV complex and is homologous to the yeast nonhomologous end-joining factor Nej1. J Biol Chem. 2006;281(20):13857-60.
175. Hentges P, Ahnesorg P, Pitcher RS, Bruce CK, Kysela B, Green AJ, et al. Evolutionary and functional conservation of the DNA non-homologous end-joining protein, XLF/cernunnos. J Biol Chem. 2006;281(49):37517-26.
176. Wu PY, Frit P, Malivert L, Revy P, Biard D, Salles B, et al. Interplay between Cernunnos-XLF and nonhomologous end-joining proteins at DNA ends in the cell. J Biol Chem. 2007;282(44):31937-43.
177. Lu H, Pannicke U, Schwarz K, Lieber MR. Length-dependent binding of human XLF to DNA and stimulation of XRCC4: DNA ligase IV activity. J Biol Chem. 2007.
178. Tsai CJ, Kim SA, Chu G. Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends. Proc Natl Acad Sci USA. 2007;104(19):7851-6.
179. Gu J, Lu H, Tsai AG, Schwarz K, Lieber MR. Single-stranded DNA ligation and XLF-stimulated incompatible DNA end ligation by the XRCC4-DNA ligase IV complex: influence of terminal DNA sequence. Nucleic Acids Res. 2007;35(17):5755-62. doi: 10.1093/nar/gkm579.
180. Riballo E, Woodbine L, Stiff T, Walker SA, Goodarzi AA, Jeggo PA. XLF-Cernunnos promotes DNA ligase IV-XRCC4 re-adenylation following ligation. Nucleic Acids Res. 2009;37(2):482-92.
181. Hammel M, Rey M, Yu Y, Mani RS, Classen S, Liu M, et al. XRCC4 protein interactions with XRCC4-like factor (XLF) create an extended grooved scaffold for DNA ligation and double strand break repair. J Biol Chem. 2011;286(37):32638-50. doi: 10.1074/jbc.M111.272641.
182. Hammel M, Yu Y, Fang S, Lees-Miller SP, Tainer JA. XLF regulates filament architecture of the XRCC4.ligase IV complex. Structure. 2010;18(11):1431-42. doi: 10.1016/j.str.2010.09.009.
183. Ropars V, Drevet P, Legrand P, Baconnais S, Amram J, Faure G, et al. Structural characterization of filaments formed by human Xrcc4-Cernunnos/XLF complex involved in nonhomologous DNA end-joining. Proc Nat Acad Sci USA. 2011;108(31):12663-8. doi: 10.1073/pnas.1100758108.
184. Yano K, Morotomi-Yano K, Lee KJ, Chen DJ. Functional significance of the interaction with Ku in DNA double-strand break recognition of XLF. FEBS Lett. 2011;585(6):841-6. doi: 10.1016/j.febslet.2011.02.020.
185. Malu S, De Ioannes P, Kozlov M, Greene M, Francis D, Hanna M, et al. Artemis C-terminal region facilitates V(D)J recombination through its interactions with DNA Ligase IV and DNA-PKcs. J Exp Med. 2012. doi: 10.1084/jem.20111437